Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.10.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 48,995 $ 23,054
Marketable securities 129,669 74,156
Receivable from collaboration   5,000
Prepaid expenses 2,594 1,208
Other current assets 304 126
Total current assets 181,562 103,544
Property and equipment, net 2,905 69
Other assets 2,280 634
Total assets 186,747 104,247
Current liabilities:    
Accounts payable 1,973 1,311
Accrued clinical expenses 8,588 2,929
Other accrued liabilities 3,854 2,828
Warrant liability   6,091
Facility loan   3,108
Accrued interest payable   43
Total current liabilities 14,415 16,310
Deferred rent, less current portion 1,914  
Facility loan, less current portion   2,990
Total liabilities 16,329 19,300
Stockholders’ equity:    
Preferred stock, $0.0001 par value: 10,000,000 shares authorized; no shares issued and outstanding
Common stock, $0.0001 par value: 100,000,000 shares authorized; 59,456,493 and 44,408,796 shares issued and outstanding as of December 31, 2018 and 2017, respectively 6 4
Additional paid-in capital 693,534 535,503
Accumulated other comprehensive loss (58) (44)
Accumulated deficit (523,064) (450,516)
Total stockholders’ equity 170,418 84,947
Total liabilities and stockholders’ equity $ 186,747 $ 104,247